/PRNewswire/ The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD,.
Group will help Center to Reduce Cancer Health Disparities determine NCI’s diversity training, biomedical workforce development, and community outreach and engagement initiatives.
While progress in outcomes has been greater in non–small cell lung cancer, recent advances, including molecularly targeted therapies against EGFR and ALK, checkpoint inhibitors that boost immune response, improved staging, and video-assisted surgery have all contributed to progress in treatment of all types of lung cancer, including in SCLC.
A team has mapped the altered protein–protein interactions resulting from mutations in cancer-associated genes, leading to a greater understanding of how cancer progresses and revealing new drug targets.
Eisai Data at ASCO 2021 Highlight Breadth of Oncology Portfolio Across Various Tumor Types prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.